China faces surge in HMPV infections, hospitals overwhelmed

China is witnessing a significant increase in respiratory infections caused by human metapneumovirus (HMPV), leading to overcrowded hospitals, emergency measures, and growing public concern.
Cases have spiked across northern Chinese provinces, particularly among children, leading to overcrowding in hospitals and prompting concerns about a potential outbreak.
While HMPV is not a new virus and typically causes mild, cold-like symptoms, the current surge has raised concerns due to its impact on vulnerable populations, including infants, the elderly, and those with weakened immune systems.
The Chinese government has implemented emergency measures to monitor and manage the spread of the virus, including a pilot program to track pneumonia cases of unknown origin.
However, the Chinese foreign ministry has downplayed the situation, stating that respiratory infections are common during the winter season.
Neighboring countries, including Hong Kong, Cambodia, and Taiwan, are closely monitoring the situation. While the World Health Organization (WHO) has not declared a global health emergency, concerns remain about the potential for wider regional spread. (ILKHA)
LEGAL WARNING: All rights of the published news, photos and videos are reserved by İlke Haber Ajansı Basın Yayın San. Trade A.Ş. Under no circumstances can all or part of the news, photos and videos be used without a written contract or subscription.
The Polio Free Afghanistan Foundation announced that a polio vaccination drive will begin tomorrow in the eastern provinces of Kunar, Nuristan, and Laghman.
Prof. Dr. Engin Yıldırım, an Obstetrics and Gynecology specialist at Malatya Training and Research Hospital and faculty member at Malatya Turgut Özal University, has called for greater public awareness about the benefits of natural childbirth.
The Turkish Statistical Institute (TurkStat) announced on Monday that the national school life expectancy (SLE) in Türkiye was 17.2 years in 2024, reflecting the expected duration of education from primary school entrance until completion of the highest level of education.
Turkish Health Minister Kemal Memişoğlu has announced that Türkiye will begin producing its own drug for spinal muscular atrophy (SMA) in the first half of 2026, marking a major milestone in the country’s efforts to tackle rare diseases and reduce dependence on foreign pharmaceuticals.